Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

OPNT

Opiant Pharmaceuticals (OPNT)

Opiant Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:OPNT
DatumZeitQuelleÜberschriftSymbolFirma
20/11/201514h46Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPNTOpiant Pharmaceuticals Inc
19/11/201517h54Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:OPNTOpiant Pharmaceuticals Inc
12/11/201512h09Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:OPNTOpiant Pharmaceuticals Inc
06/11/201512h07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPNTOpiant Pharmaceuticals Inc
30/10/201511h14Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OPNTOpiant Pharmaceuticals Inc
30/10/201511h10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPNTOpiant Pharmaceuticals Inc
30/10/201511h07Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OPNTOpiant Pharmaceuticals Inc
29/10/201521h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPNTOpiant Pharmaceuticals Inc
26/10/201521h34Edgar (US Regulatory)Annual Report (10-k)NASDAQ:OPNTOpiant Pharmaceuticals Inc
12/06/201515h06Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OPNTOpiant Pharmaceuticals Inc
03/06/201521h34Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPNTOpiant Pharmaceuticals Inc
03/06/201515h34PR Newswire (US)Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Commences Rolling NDA Submission To The FDA For Intranasal Naloxon...NASDAQ:OPNTOpiant Pharmaceuticals Inc
22/04/201515h00PR Newswire (US)Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Successfully Completed Intranasal Naloxone StudyNASDAQ:OPNTOpiant Pharmaceuticals Inc
13/04/201519h20Dow Jones NewsMicrosoft Brings Back DelBene for New Senior Strategy PostNASDAQ:OPNTOpiant Pharmaceuticals Inc
13/04/201519h06Dow Jones NewsMicrosoft Brings Back Kurt DelBene for New Senior Strategy PostNASDAQ:OPNTOpiant Pharmaceuticals Inc
17/03/201521h28Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OPNTOpiant Pharmaceuticals Inc
17/02/201515h00PR Newswire (US)Lightlake Therapeutics Inc. Announces Fast Track Designation From The United States Food And Drug Administration For Intranas...NASDAQ:OPNTOpiant Pharmaceuticals Inc
17/02/201515h00PR Newswire (US)Lightlake Therapeutics Inc. Announces Fast Track Designation From The United States Food And Drug Administration For Intranas...NASDAQ:OPNTOpiant Pharmaceuticals Inc
09/02/201515h00PR Newswire (US)Lightlake Therapeutics Inc. Announces Arvind Agrawal Appointed Executive Vice President, Medical AffairsNASDAQ:OPNTOpiant Pharmaceuticals Inc
09/02/201515h00PR Newswire (US)Lightlake Therapeutics Inc. Announces Arvind Agrawal Appointed Executive Vice President, Medical AffairsNASDAQ:OPNTOpiant Pharmaceuticals Inc
29/12/201422h03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPNTOpiant Pharmaceuticals Inc
16/12/201415h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPNTOpiant Pharmaceuticals Inc
16/12/201414h30PR Newswire (US)Lightlake Therapeutics Inc. Announces Licensing Deal With Adapt Pharma Limited SubsidiaryNASDAQ:OPNTOpiant Pharmaceuticals Inc
16/12/201414h30PR Newswire (US)Lightlake Therapeutics Inc. Announces Licensing Deal With Adapt Pharma Limited SubsidiaryNASDAQ:OPNTOpiant Pharmaceuticals Inc
10/12/201414h30Edgar (US Regulatory)Securities Registration (section 12(g)) (8-a12g)NASDAQ:OPNTOpiant Pharmaceuticals Inc
09/12/201420h09Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OPNTOpiant Pharmaceuticals Inc
05/12/201421h23Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPNTOpiant Pharmaceuticals Inc
04/12/201415h17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPNTOpiant Pharmaceuticals Inc
04/12/201415h00PR Newswire (US)Lightlake Therapeutics Commences Trial For Treatment Of Opioid Overdose With The U.S. National Institute On Drug Abuse (NIDA)NASDAQ:OPNTOpiant Pharmaceuticals Inc
04/12/201415h00PR Newswire (US)Lightlake Therapeutics Commences Trial For Treatment Of Opioid Overdose With The U.S. National Institute On Drug Abuse (NIDA)NASDAQ:OPNTOpiant Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:OPNT

Kürzlich von Ihnen besucht

Delayed Upgrade Clock